Form 4: Agenus Inc. Insider Trades: Garo H. Armen Salary Paid in Stock

Garo H. Armen, Director and CEO of Agenus Inc., received 4,540 shares of common stock valued at $3.58 per share as payment for his salary for the pay period ending May 15, 2026.

Summary

• Garo H. Armen, who holds positions as Director, CEO, and Principal Financial Officer at Agenus Inc., had his salary for the pay period ending May 15, 2026, paid in stock instead of cash.
• A total of 4,540 shares of common stock were issued to Dr. Armen, with each share valued at $3.58, which was the closing price on May 15, 2026.
• These shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested upon issuance.
• Following this transaction, Dr. Armen beneficially owns 351,323 shares of common stock directly.
• Additionally, he has indirect beneficial ownership of 31,298 shares held in his IRA accounts and 28,950 shares held through the Garo Armen 2020 2 Year AG GRAT.
• He is also a general partner in Pixie Partners, which owns 5,000 shares, though Dr. Armen disclaims beneficial ownership for a portion of these shares due to his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a standard executive compensation transaction without indicating significant positive or negative financial performance or strategic shifts.

Positives

• Company is utilizing stock to compensate its CEO, potentially conserving cash.
• The CEO's salary is being paid in fully vested stock, aligning his interests with shareholders.
• The transaction occurred at the closing price of the stock on the transaction date, indicating a fair valuation.
• Garo H. Armen continues to hold a significant number of shares, both directly and indirectly, demonstrating continued commitment to the company.

Negatives

• The company is paying its CEO in stock, which could indicate cash flow constraints or a strategic decision to preserve cash.
• The value of the stock received is tied to the market price, which can be volatile.

Risks

• The value of the CEO's compensation is subject to market fluctuations in Agenus Inc.'s stock price.
• Indirect ownership through various entities (IRA, GRAT, Partnership) introduces complexity in tracking beneficial ownership and potential conflicts of interest.

Future Outlook

This filing does not contain specific forward-looking statements or guidance. It is a report of a past transaction.

Management Comments

• "At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash."
• "The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 15, 2026."
• "Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance."
• "$3.58 is the closing price of our Common Stock on May 15, 2026, the last trading day for the payroll date for the pay period ending May 15, 2026."

Industry Context

StockSavvy.ai notes that the practice of paying executive salaries in stock is common in the biotechnology and pharmaceutical sectors, particularly for companies like Agenus Inc. that may be focused on R&D and cash preservation. This aligns executive compensation with shareholder value, a trend observed across the industry.

Related Party Transactions

• Garo H. Armen's salary for the pay period ending May 15, 2026, was paid in Agenus Inc. common stock, as approved by the Compensation Committee.

Stakeholder Impact

• Shareholders: The issuance of stock for salary may dilute existing share ownership slightly, but it also aligns executive interests with shareholder value. The value of their holdings is directly impacted by the stock price.
• Employees: This transaction highlights a compensation strategy that may be common within the company, potentially influencing how other employees are compensated.
• Management: Garo H. Armen's compensation is directly tied to the company's stock performance.

Next Steps

• Continue to monitor future SEC filings for any further changes in beneficial ownership or executive compensation.
• Observe the market performance of Agenus Inc. stock to assess the value of the compensation received by Garo H. Armen.

Key Dates

Keywords

Agenus Inc., Garo H. Armen, Form 4, Insider Trading, Stock Compensation, CEO Salary, Beneficial Ownership, Equity Incentive Plan, SEC Filing, AGEN